471 related articles for article (PubMed ID: 32379307)
1. Statin therapy and SAR-COV-2: an available and potential therapy?
Abdel-Latif RG; Mohammed S; Elgendy IY
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):333-334. PubMed ID: 32379307
[No Abstract] [Full Text] [Related]
2. Statins in coronavirus outbreak: It's time for experimental and clinical studies.
Bifulco M; Gazzerro P
Pharmacol Res; 2020 Jun; 156():104803. PubMed ID: 32289478
[No Abstract] [Full Text] [Related]
3. Considerations for Statin Therapy in Patients with COVID-19.
Dashti-Khavidaki S; Khalili H
Pharmacotherapy; 2020 May; 40(5):484-486. PubMed ID: 32267560
[No Abstract] [Full Text] [Related]
4. Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19.
DiNicolantonio JJ; Barroso J; McCarty M
Open Heart; 2020 Sep; 7(2):. PubMed ID: 32895293
[No Abstract] [Full Text] [Related]
5. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
Nisole S; Saulnier A; Gatignol A
Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
[No Abstract] [Full Text] [Related]
6. Surviving COVID-19: A disease tolerance perspective.
Ayres JS
Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
[No Abstract] [Full Text] [Related]
7. Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus.
McCarty MF; DiNicolantonio JJ
Prog Cardiovasc Dis; 2020; 63(3):383-385. PubMed ID: 32061635
[No Abstract] [Full Text] [Related]
8. Sofosbuvir for COVID-19 infection: A potential candidate.
Gupta R; Dhamija P
Indian J Pharmacol; 2020; 52(3):232-233. PubMed ID: 32874010
[No Abstract] [Full Text] [Related]
9. Is the type of diabetes treatment relevant to outcome of COVID-19?
Bloomgarden Z
J Diabetes; 2020 Jul; 12(7):486-487. PubMed ID: 32353193
[No Abstract] [Full Text] [Related]
10. Covid-19: Time for a paradigm change.
Buonaguro FM; Ascierto PA; Morse GD; Buonaguro L; Puzanov I; Tornesello ML; Bréchot C; Gallo RC
Rev Med Virol; 2020 Sep; 30(5):e2134. PubMed ID: 32618072
[No Abstract] [Full Text] [Related]
11. COVID-19 update: Covid-19-associated coagulopathy.
Becker RC
J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
[No Abstract] [Full Text] [Related]
12. Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.
Greco A; Buccheri S; D'Arrigo P; Calderone D; Agnello F; Monte M; Milluzzo RP; Franchina AG; Ingala S; Capodanno D
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):335-337. PubMed ID: 32671399
[No Abstract] [Full Text] [Related]
13. A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.
Ren YR; Golding A; Sorbello A; Ji P; Chen J; Saluja B; Witzmann K; Arya V; Reynolds KS; Choi SY; Nikolov NP; Sahajwalla C
J Clin Pharmacol; 2020 Aug; 60(8):954-975. PubMed ID: 32469437
[TBL] [Abstract][Full Text] [Related]
14. Deep venous thrombosis in a non-critically ill patient with novel COVID-19 infection.
Nauka PC; Oran E; Chekuri S
Thromb Res; 2020 Aug; 192():27-28. PubMed ID: 32419710
[TBL] [Abstract][Full Text] [Related]
15. Using "old" medications to fight new COVID-19: Re-purposing with a purpose.
Wang Y; Foo R; Thum T
J Mol Cell Cardiol; 2020 Sep; 146():41-42. PubMed ID: 32687852
[No Abstract] [Full Text] [Related]
16. Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemic.
Qian K; Hu S
MAbs; 2020; 12(1):e1782600. PubMed ID: 32546047
[TBL] [Abstract][Full Text] [Related]
17. Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia.
Bou Khalil R
Med Hypotheses; 2020 Sep; 142():109798. PubMed ID: 32413699
[No Abstract] [Full Text] [Related]
18. COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response.
Ryan PM; Caplice N
Open Heart; 2020 Jun; 7(1):. PubMed ID: 32532804
[No Abstract] [Full Text] [Related]
19. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach.
Sarma P; Prajapat M; Avti P; Kaur H; Kumar S; Medhi B
Indian J Pharmacol; 2020; 52(1):1-5. PubMed ID: 32201439
[No Abstract] [Full Text] [Related]
20. Coronavirus disease 2019 infection and the cardiovascular system.
Romeo F; Calcaterra G; Barilla F; Mehta JL
J Cardiovasc Med (Hagerstown); 2020 Jun; 21(6):403-405. PubMed ID: 32324641
[No Abstract] [Full Text] [Related]
[Next] [New Search]
